Lufang Zhou, PhD, is a professor of biomedical engineering and surgery at The Ohio State University. His research focuses on developing innovative technologies to target and disrupt cancer cells, particularly mitochondria, the cell’s energy-producing structures. Zhou is known for his work on light-activated gene therapies and nanotechnology-based approaches aimed at improving cancer treatment while minimizing harm to healthy tissue. His contributions have the potential to advance targeted therapies for difficult-to-treat cancers like glioblastoma and triple-negative breast cancer.